首页|四川省防控抗肿瘤药物治疗相关恶心呕吐专家共识2024版

四川省防控抗肿瘤药物治疗相关恶心呕吐专家共识2024版

扫码查看
恶心呕吐是抗肿瘤药物治疗中最常见的副作用之一,极大地影响患者的生活质量和治疗效果.及时有效地预防和控制恶心呕吐具有重要意义.结合四川省的医疗现状和相关研究成果,我们制订了《四川省防控抗肿瘤药物治疗相关恶心呕吐专家共识2024版》.本共识致力于为临床医师提供符合四川省情的防控抗肿瘤药物治疗相关恶心呕吐的专业建议和指导.
Expert consensus on the prevention and treatment of anti cancer drug induced nausea and vomiting of Sichuan province(2024)
Nausea and vomiting are common side effects of anti cancer drug therapy,and significantly impact patient quality of life and treatment efficacy.Timely and effective prevention and management of these symptoms are crucial.In consideration of the healthcare situation in Sichuan province and relevant research findings,we have updated the"Expert consensus on the prevention and treatment of anti cancer drug induced nausea and vomiting of Sichuan province(2024)".This consensus aims to provide clinicians with professional advice and guidance tailored to the conditions in Sichuan province.

NauseaVomitingAnti cancer drug therapyConsensusSichuan province

《四川省防控抗肿瘤药物治疗相关恶心呕吐专家共识》编写专家组、朱江

展开 >

恶心 呕吐 抗肿瘤药物治疗 专家共识 四川省

四川省科技厅重点研发项目

23ZDYF2835

2024

中国循证医学杂志
四川大学

中国循证医学杂志

CSTPCD北大核心
影响因子:1.761
ISSN:1672-2531
年,卷(期):2024.24(10)